Ghang, Byeongzu
Nam, So Hye
Choi, Wonho
Kim, Hwa Jung
Lee, Jungsun
Lim, Doo-Ho
Ahn, Soo Min
Oh, Ji Seon
Hong, Seokchan
Kim, Yong-Gil
Lee, Chang-Keun
Kim, Jinseok
Yoo, Bin
Nam, Soo Jeong
Funding for this research was provided by:
Jeju National University Hospital (2021-39)
Article History
Received: 28 March 2024
Accepted: 2 July 2024
First Online: 30 July 2024
Declarations
:
: The study protocol was approved by the Institutional Review Board of Asan Medical Center (approval #2021 − 0881; approval date: October 10, 2021).
: Not applicable.
: Byeongzu Ghang is the CEO of InDream Healthcare Inc., a digital healthcare company that develops an automatic drug interaction searching program and app (https://www.medi-chart.com). Byeongzu Ghang, Bin Yoo, and Soo Jeong Nam, along with their affiliated institutions, hold patents related to this research that are restricted to Korea.